BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 9224651)

  • 1. A rapid quantitative assay for the detection of mammalian heparanase activity.
    Freeman C; Parish CR
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):229-37. PubMed ID: 9224651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet heparanase: purification, characterization and catalytic activity.
    Freeman C; Parish CR
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that platelet and tumour heparanases are similar enzymes.
    Freeman C; Browne AM; Parish CR
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):361-8. PubMed ID: 10455023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity.
    Nakajima M; Irimura T; Nicolson GL
    Anal Biochem; 1986 Aug; 157(1):162-71. PubMed ID: 3766958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells.
    Nakajima M; Irimura T; Nicolson GL
    Cancer Lett; 1986 Jun; 31(3):277-83. PubMed ID: 3719568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.
    Nakajima M; Irimura T; Di Ferrante N; Nicolson GL
    J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanases and tumor metastasis.
    Nakajima M; Irimura T; Nicolson GL
    J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
    Irimura T; Nakajima M; Nicolson GL
    Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; Nicolson GL
    Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
    Ricoveri W; Cappelletti R
    Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
    Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
    J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
    Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
    Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase activity in cultured endothelial cells.
    Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
    J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
    Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
    Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
    Vlodavsky I; Friedmann Y; Elkin M; Aingorn H; Atzmon R; Ishai-Michaeli R; Bitan M; Pappo O; Peretz T; Michal I; Spector L; Pecker I
    Nat Med; 1999 Jul; 5(7):793-802. PubMed ID: 10395325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.